Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomicsBetty M. Tijms, Pieter Jelle Visser, Johan Gobom et al.|Brain|2020Cited by 221
Inflammatory biomarkers in Alzheimer's disease plasmaAngharad R. Morgan, B. Paul Morgan, Samuel Touchard et al.|Alzheimer s & Dementia|2019Cited by 207
A hexanucleotide repeat modifies expressivity of X‐linked dystonia parkinsonismAna Westenberger, Christine Klein, Karen Grütz et al.|Annals of Neurology|2019Cited by 96
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levelsShengjun Hong, Lars Bertram, Valerija Dobričić et al.|Alzheimer s & Dementia|2021Cited by 43
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF‐AD studyRebecca G. Smith, Katie Lunnon, Ehsan Pishva et al.|Alzheimer s & Dementia|2024Cited by 16